Registry of Cardiovascular Disease Patients

Atrial Fibrillation Clinical Trial

— CVD Registry  

Official title:

Computerized Registry of Cardiovascular Disease Patients

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT01759225
• Other study ID #: MACCVREG1
• Secondary ID: cvdregistry
• Status: Enrolling by invitation
• Phase: N/A
• First received: December 18, 2012
• Last updated: December 27, 2012
• Start date: January 1998

Study information

• Verified date: December 2012
• Source: Maccabi Healthcare Services, Israel
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States:Department of Health and Human Services
• Study type: Observational [Patient Registry]

Clinical Trial Summary

A computerized registry of cardiovascular disease patients in a large health maintenance organization in Israel. The registry is aimed to be used by health professionals to identify cardiovascular disease patients and to follow the courses of their illnesses and risk factors.

Description:

The registry was initiated in 1998 by Maccabi Healthcare services, which is the second largest publicly funded HMO in Israel,serving 24% of the total population with a nationwide distribution.

The registry uses advanced information technology that integrates personal computerized community and hospital records, data from laboratory tests, dispensed medications, physiological signals, radiological images, and reports from investigations and procedures.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 110000
• Est. primary completion date: December 2100
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Clinical Diagnosis of the following:

Ischemic Heart Disease,MI,non-MI,congestive heart failure,peripheral vascular disease, cerebrovascular disease CVA,TIA,patients with first AMI diagnosis from community physicians if they were hospitalized for lasting at least 3 days during a 30-day period prior to diagnosis.

• Patients with prior coronary artery bypass grafting(CABG) or percutaneous coronary intervention (PCI), using relevant Current Procedural Terminology (CPT) codes

Exclusion Criteria:

• patients who were diagnosed as suffering from CHD by primary physician or general hospitals prior to 2000 with no further indication

• Patients whose primary physician reported that the patient is CHD-free providing adequate medical records

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Atherosclerosis
• Atrial Fibrillation
• Cardiovascular Diseases
• Cerebrovascular Atherosclerosis
• Cerebrovascular Disease
• Cerebrovascular Disorders
• Congestive Heart Failure
• Coronary Artery Disease
• Heart Failure
• Ischemic Heart Disease
• Myocardial Ischemia
• Peripheral Arterial Disease
• Peripheral Vascular Disease
• Peripheral Vascular Diseases
• Vascular Diseases

Locations

Country	Name	City	State
Israel	Maccabi Healthcare Services	Tel Aviv

Sponsors (1)

Lead Sponsor	Collaborator
Maccabi Healthcare Services, Israel

Country where clinical trial is conducted

Israel, 

References & Publications (1)

Shalev V, Chodick G, Goren I, Silber H, Kokia E, Heymann AD. The use of an automated patient registry to manage and monitor cardiovascular conditions and related outcomes in a large health organization. Int J Cardiol. 2011 Nov 3;152(3):345-9. doi: 10.1016 — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	hospitalization days due to CVD		up to 100 years	No
Primary	Number of Patients with Cardiovascular disease		Up to 100 years	No
Secondary	prevalence rates of CVD		up to 100 years	No
Secondary	Major Adverse Cardiac Events		up to 100 years	No
Secondary	Number of LDL Tests performed reaching target LDL		up to 100 years	No
Secondary	Proportion of dyslipidemia patients treated with Statins		up to 100 years	No

External Links

•   Link